If this box remains here for more than 30 seconds, click this link to try again.
Products & Services »
Best Practice Database
Sales and Marketing » New Product Development and Launch » Planning and Coordinating Launch » Communication Activities
Download FREE Excerpt
Single User: Authorizes use by the person who places the order or for whom the order was placed.
Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.
Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.
This case study reviews the failed strategy and tactics utilized by Pfizer for the launch of its inhaled insulin product Exubera for diabetes. The study reviews the pharma giant's missteps with payers, consumers and KOLs as it launched the product. Pfizer expected a blockbuster because of Exubera's perceived delivery system advantages over insulin injections but the product flopped - despite Pfizer's substantial marketing efforts - and was dropped by the company less than a year after launch. Executives and managers can use this research to gain insights into the sometimes-difficult process of winning key support from payers, consumers and physicians for a product with different characteristics than existing products.